GICS Sector : Healthcare
Hyperfine, Inc.provides imaging, monitoring, and magnetic resonance imaging products.It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services.
Hyperfine reported revenue of $3.4 million, a 27% sequential increase, and expanded gross margins to a record 54%, driven by a record average selling price of $361,000. The company's EPS loss was $0.11, slightly wider than the estimated loss of $0.1. The significant reduction in cash burn, down 27% sequentially, excluding financing, and the recent capital raise of over $20 million, extending the cash runway into 2027, are positive indicators. With the current P/S Ratio of 7.95, investors are pricing in significant growth expectations.
Publication Date: Nov -20
The company has made significant strides in its commercial verticals, including hospital, office, and international markets. The next-generation subsystem and Optive AI software have triggered an activation of commercial deals, with interest from multiple sites of care. As Brett Hale mentioned, the fourth quarter is expected to be the second quarter of the launch for the next-generation technology, with a subset of the converted hospital deals to land in Q4. The robust pipeline, with a growth rate exceeding previous quarters, is a positive sign for future revenue growth.
Hyperfine guided 2025 revenue to be between $5 to $6 million, with a gross margin range of 49% to 51%. The company's cash burn is expected to be between $29 million to $31 million. Analysts estimate next year's revenue growth at 35.4%. The company's diversified pipelines across geographies and verticals, including US hospital deals, US office deals, and international business, are expected to drive growth. Maria Sainz refrained from providing 2026 guidance, choosing to reserve commentary until the beginning of 2026 with a closed Q4.
With a P/E Ratio of -2.11 and an EV/EBITDA of -1.6, the market is pricing in significant growth expectations. The P/B Ratio of 3.15 and P/S Ratio of 7.95 indicate that investors are expecting substantial revenue and earnings growth in the future. The company's ROE and ROIC are negative, but this is expected given the company's current stage of growth. As the company continues to execute on its commercial launch and growth trajectory, investors will be watching closely for progress in the coming quarters.
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Nov -20
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Nov -19
Head to Head Review: Hyperfine (NASDAQ:HYPR) vs. Vasamed (OTCMKTS:VSMD)
Nov -16
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Nov -14
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Nov -14
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
Nov -13
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
Oct -21
Hyperfine Announces Pricing of $17.5 Million Public Offering
Oct -16
Hyperfine, Inc.'s 10.27% growth is driven by increasing adoption of its portable MRI technology, expanding into new markets, and growing demand for point-of-care diagnostics. Additionally, strategic partnerships, innovative product offerings, and cost-effective solutions contribute to the company's rapid growth.
Hyperfine's device growth is driven by increasing demand for portable MRI systems, advancements in AI-powered imaging, and expanding access to healthcare in emerging markets. Additionally, the device's low cost, ease of use, and ability to provide real-time imaging results contribute to its rapid adoption in various medical settings.
Portable MRI system designed for point-of-care imaging, providing high-quality images in a compact and affordable package
Advanced software platform for image acquisition, processing, and analysis, providing high-quality MRI images
Cloud-based platform for data management, analysis, and collaboration, enabling secure and efficient data sharing
Artificial intelligence and machine learning algorithms for image analysis and interpretation, enhancing diagnostic accuracy
Hyperfine, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the evolving nature of the industry.
Hyperfine, Inc. has a diverse customer base, which reduces the bargaining power of individual customers, and the company's products are highly specialized, making it difficult for customers to switch to alternative suppliers.
Hyperfine, Inc. relies on a few key suppliers for critical components, which gives them some bargaining power, but the company's strong relationships with suppliers and its ability to negotiate contracts mitigate this risk.
The market for Hyperfine, Inc.'s products is attractive, and the company's intellectual property and expertise in the field create barriers to entry, but the threat of new entrants is still high due to the rapidly evolving nature of the industry.
Hyperfine, Inc. operates in a competitive market, but the company's unique products and strong brand recognition help to differentiate it from competitors, reducing the intensity of rivalry.
| Value | |
|---|---|
| Debt Weight | 0.29% |
| Debt Cost | 3.95% |
| Equity Weight | 99.71% |
| Equity Cost | 8.01% |
| WACC | 8.00% |
| Leverage | 0.30% |
Value: 6.8
Growth: 7.4
Quality: 4.0
Yield: 0.0
Momentum: 9.0
Volatility: 0.7
1-Year Total Return ->
Value: 7.4
Growth: 3.3
Quality: 4.6
Yield: 0.0
Momentum: 8.0
Volatility: 3.0
1-Year Total Return ->
Value: 8.0
Growth: 6.4
Quality: 3.7
Yield: 0.0
Momentum: 4.0
Volatility: 3.7
1-Year Total Return ->
Value: 6.8
Growth: 2.9
Quality: 3.6
Yield: 0.0
Momentum: 9.5
Volatility: 0.7
1-Year Total Return ->
Value: 7.6
Growth: 4.7
Quality: 3.9
Yield: 0.0
Momentum: 3.0
Volatility: 1.0
1-Year Total Return ->
Value: 10.0
Growth: 1.6
Quality: 5.2
Yield: 0.0
Momentum: 0.0
Volatility: 0.0
1-Year Total Return ->